ストックスクリーナーアプリを入手
0.344
4.44%
-0.016
前日終値:
$0.36
開ける：
$0.353
24時間の取引高:
2.03M
Relative Volume:
4.53
時価総額：
$16.72M
収益：
$1.14M
当期純損益:
$-56.27M
株価収益率:
-0.2834
EPS:
-1.2139
ネットキャッシュフロー:
$-51.94M
1週間 パフォーマンス:
-5.75%
1か月 パフォーマンス:
-33.22%
6か月 パフォーマンス:
-67.85%
1年 パフォーマンス:
-71.57%
1日の値動き範囲:
$0.338
$0.4067
1週間の範囲:
$0.338
$0.4159
52週間の値動き範囲:
$0.338
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.344 | 18.90M | 1.14M | -56.27M | -51.94M | -1.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
RA Capital adjusts Werewolf Therapeutics (HOWL) stake to 10.6% ownership - Stock Titan
Werewolf Therapeutics Stock (US4433141076): valuation back in focus after recent pipeline updates - AD HOC NEWS
Werewolf Therapeutics Stock (US4433141076): Quarterly earnings keep biotech micro-cap in focus - AD HOC NEWS
Ra Capital sells $253,568 in Werewolf Therapeutics (NASDAQ:HOWL) stock - Investing.com
RA Capital funds trim Werewolf Therapeutics (HOWL) stake with 678K-share sale - Stock Titan
Werewolf Therapeutics director Evnin sells $28,463 in company stock - Investing.com UK
Werewolf Therapeutics (HOWL) entities linked to Luke Evnin sell 76,928 shares - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Werewolf Therapeutics director Luke Evnin sells $43,028 in shares - Investing.com UK
Werewolf Therapeutics director Luke Evnin sells $43,028 in shares By Investing.com - Investing.com India
Werewolf Therapeutics (NASDAQ: HOWL) director’s entities sell shares - Stock Titan
Werewolf Therapeutics director Luke Evnin sells $63,628 in stock - Investing.com
Werewolf Therapeutics director Luke Evnin sells $63,628 in stock By Investing.com - Investing.com Australia
Werewolf Therapeutics (NASDAQ: HOWL) director-affiliated funds sell 139,803 shares - Stock Titan
Werewolf Therapeutics Stock Stalls While HOWL Holds for Strategic Update - Bez Kabli
Werewolf Therapeutics (HOWL) Slips to $0.45 as Biotech Stock Holds Near Critical SupportDark Pool Volume - newsline.com
Werewolf Therapeutics Inc. Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Progress ContinuesCEO Earnings Statement - The Legal Advocate
What's Behind the Recent Insider Selling at Werewolf Therapeutics (HOWL) - Kavout
Werewolf Therapeutics director Luke Evnin sells $66,200 in shares By Investing.com - Investing.com India
Werewolf Therapeutics director Luke Evnin sells $66,200 in shares - Investing.com
Director-linked funds trim Werewolf (NASDAQ: HOWL) stake via 141K-share sale - Stock Titan
[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan
Werewolf Therapeutics (HOWL) Slides 7.6% as Shares Test Key Support at $0.43VOLD Alert - The Legal Advocate
MPM-linked funds tied to Werewolf (NASDAQ: HOWL) sell 191,762 shares under plan - Stock Titan
HOWL Q1 2026 Earnings: EPS Beats Estimates as Biotech Continues Pipeline ProgressBook Value Growth - The Legal Advocate
HOWL Q1 2026 Earnings: Narrowed Loss Exceeds Estimates, Stock RisesProfit Announcement - Newser
Werewolf Therapeutics (HOWL) Stages a Modest Rebound: Can the $0.44 Level Hold?Impulse Wave - The Legal Advocate
- The Legal Advocate
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock By Investing.com - Investing.com India
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock - Investing.com UK
Evnin-linked funds sell 171K Werewolf Therapeutics (HOWL) shares - Stock Titan
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
Werewolf Therapeutics (HOWL) Stock: Down -3.84%, Support Test at $0.47 2026-05-18ATR Levels - newser.com
Werewolf Therapeutics (HOWL) price target increased by 12.00% to 7.14 - MSN
Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
Werewolf Therapeutics Inc (HOWL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 16 '26 |
Sale |
0.37 |
149,625 |
55,361 |
331,414 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 15 '26 |
Sale |
0.39 |
128,770 |
50,220 |
341,353 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 09 '26 |
Sale |
0.37 |
369,800 |
136,826 |
381,717 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 11 '26 |
Sale |
0.38 |
262,503 |
99,751 |
361,229 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Jun 10 '26 |
Sale |
0.37 |
45,923 |
16,992 |
378,666 |
| EVNIN LUKE | Director |
Jun 09 '26 |
Sale |
0.37 |
76,928 |
28,463 |
300,283 |
| EVNIN LUKE | Director |
Jun 08 '26 |
Sale |
0.40 |
60,547 |
24,219 |
377,211 |
| EVNIN LUKE | Director |
Jun 05 '26 |
Sale |
0.40 |
24,946 |
9,978 |
437,758 |
| EVNIN LUKE | Director |
Jun 04 '26 |
Sale |
0.44 |
20,072 |
8,832 |
462,704 |
| EVNIN LUKE | Director |
Jun 01 '26 |
Sale |
0.47 |
80,459 |
37,816 |
542,120 |
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):